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Abstract 
Background: This experimental study was carried 
out to compare the number of mast cells in major 
salivary glands of albino rat in hypothyroid state. 
Methods: An experimental study was carried out 
on twenty male albino rats, weighing between 130-
150 grams. The rats were divided into two groups; 
control group (A) and an experimental group (B), 
with 10 animals in each group. Hypothyroid 
condition was modeled in albino rats of 
experimental group (B) by giving them 0.02% w/v 
Methimazole (MMI) for three weeks in drinking 
water. After 4-weeks animals from both the groups 
were euthanized with chloroform. The blood sample 
was taken from each rat for determination of thyroid 
hormone concentrations in the serum by cardiac 
puncture. Serum T3, T4 and TSH levels were 
determined by enzyme immunoassay to confirm 
hypothyroid state of the animal. Major salivary 
glands; parotid, submandibular and sublingual were 
dissected and removed from the body. They were 
fixed in Bouin’s solution. Glands were further 
processed for light microscopy and for histological 
analysis of mast cells Toluidine blue stain was used. 
Counting of mast cells (MCs) was performed by 
superimposing the ocular graticule on the salivary 
gland preparation. 
Results: Statistically significant difference was 
observed between the MCs  of parotid gland in 
group A (2.25±1.34/mm2) and B (3.70+1.11/mm2), 
p<0.017. No significant difference was observed in 
the mean number of MCs  in the sublingual and 
submandibular salivary glands with p=0.511 and 
p=0.187 respectively. 
Conclusion: In hypothyroid state, there is 
significant difference in the number of MCs in the 
parotid glands and there is no significant difference 
in the number of MCs of submandibular and 
sublingual glands. 
Key Words:Mast cells,Salivary glands, 
Hypothyroidism,Methimazole (MMI) 
Introduction 
Mast cells (MCs) are leukocytes originating from 
haematopoietic progenitor cells. Initially circulating in 
the blood in an immature form they reach their final 
maturation after they migrate to vascularised tissues 
with the help of stem-cell factor and other cytokines. 
Endothelial cells and fibroblasts secrete these 
cytokines.1-,3 
MCs have been implicated in many immune-
inflammatory disorders.2,4,5, Being multifunctional they 
play a cardinal role in innate and adaptive immunity 
against microbial infections along with initiating IgE 
dependant allergic diseases.6 MCs are ideally located 
to participate in the early recognition of the pathogens 
specifically in areas that are in close contact with the 
external enviourment.3,6 They are located strategically 
at host/environment interfaces like skin, airways, 
gastrointestinal and urogenital tracts. MCs also 
populate connective tissue in association with blood 
and lymphatic vessels and nerves.7  They play a 
leading role in inflammatory processes, allergic 
reactions and in autoimmune disease pathogenesis 
since they produce various cytokines.1,5 MCs having 
different locations have numerous histochemical, 
cytochemical, ultra structural, and functional 
properties.8 They are also thought to play a role in 
angiogenesis, tissue remodelling, wound healing, and 
tumour repression or growth. Due to their phenotypic 
adaptability to different tissue micro-environment  
and their ability to generate and release a diverse 
array of bioactive mediators in response to multiple 
types of cell surface and cytosolic receptors they elicit 
both physiologic and pathologic role owing to their 
flexible nature.9 
MC distribution has shown to be altered in various 
fibroproliferative disorders like pterygium, wound 
healing and rhinoscleroma.2 Prominent increase in  
MCs was observed in lesions of breast like mammary 
dysplasia, fibroadenoma and scirrhous carcinoma of 
breast.2 Various salivary gland conditions as 
sialadenitits, pleomorphic adenoma and 
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cystadenolymphoma showed increased number of 
degranulating mast cells as well.2 
Pathological MCs can accumulate in potentially any or 
all organs and tissues and result in aberrant release of 
variable subsets of mast cells mediators resulting in 
mast cell activation disease (MCAD). Disorders of 
thyroid gland is one of the disease which should be 
considered as differential diagnosis of mast cell 
activation disease since they mimick or may be 
associated with mast cell activation.10 MCs influence 
thyroid function; treatment with disodium 
cromoglycate (mast cells stabilizer) partially blocked 
the TSH actions on thyroid gland, thus evidencing that 
thyroidal mast cells act as an intermediary factor of 
TSH actions on thyroid gland. Furthermore, both T3 
and T4 concentrations were increased after compound 
BW48-80 (mast cell disrupter polymer), which 
confirmed the active participation of mast cells on TSH 
secretion.11 
Histological analysis of thyroid gland in methimazole-
induced hypothyroid rat revealed MCs in the vicinity 
of the capillaries and stroma of hypertropic connective 
tissue.12 Increase in amount of MCs was also 
documented in hypothyroid female skin when 
experimental group was compared to the control.1 
MCs further detect events in mediator cascade and this 
is why quantity of mast cells increased in maternal 
hypothyroidism1.  Number of MCs were significantly 
increased in sublingual gland of hypothyroid rat 6-
weeks after thyroidectomy indicating a pathology in 
the gland.1 Therefore increased MCs are associated 
with different pathological conditions, but the 
functional significance of these cells in the pathological 
processes is mostly unknown. 
One of the most frequent thyroid disorder in humans 
is hypothyroidism in which production of the thyroid 
hormones decreases below the normal level.12The 
hypothyroid state is a complex hormonal dysfunction 
rather than a single hormonal defect, manifested 
largely by a reversible slowing down of all body 
functions13,14. In 1989, it was reported that enlarged 
salivary glands were common in patients with 
hypothyroidism (myxoedema), but this finding was 
not widely accepted. It had been suggested that 
parotid, submandibular and in particular the 
sublingual gland were discernibly enlarged and 
served as a useful clue to the diagnosis of 
hypothyroidism.15 
Regarding their morphology, histochemistry and ultra 
structure, the salivary glands of rats had been the 
subject of immense interest for researchers. The 
histological aspects of salivary glands had not been 
sufficiently studied in hypothyroid state though 
investigations regarding its physiological and 
biochemical effects received sufficient attention.16,17  
 A correlation existed between autoimmune thyroiditis 
and salivary gland dysfunction / Sjӧgren’s 
syndrome18,19. Sjogren’s syndrome and 
hypothyroidism both resulted in xerostomia.18In 
Sjӧgren’s syndrome, salivary glands gradually become 
filled with inflammatory cells. Mast cells were 
previously studied by metachromatic toulidine blue 
staining of labial salivary glands where study showed 
that number of mast cells was higher in patients than 
in healthy controls.4 
Any alterations in the integrity and activity of the 
salivary glands can change salivary flow and its 
composition, thus affecting patient’s nutritional intake 
causing additional stress and depression. Therefore, 
the research on the salivary glands has not only 
significant medical but also social implications. 
Histological analysis of the salivary glands after 
administration of a variety of drugs and pathological 
conditions had been illustrated in a number of studies, 
but it is evident that information about the presence or 
absence of MCs in salivary glands in hypothyroid state 
is insufficient.20-22  
 
Material and Methods 
Twenty male Albino rats, 42-60 days old, weighing 
between 130-150 grams were procured from the 
National Institute of Health, Islamabad. All the 
animals were examined thoroughly for health status 
before the commencement of the experiment. The rats 
were housed in the Research laboratory of University 
of Health Sciences, Lahore under controlled conditions 
of temperature 22 + 0.5ºC, humidity 50 + 10%, 12 
hours light/dark cycle; and the animals were fed on 
rat chow, tap water ad libitum and were acclimatized 
for a period of one week. Twenty male Albino rats 
were divided into two groups of 10 each; Group A 
served as control whereas Group B was used as an 
experimental group. Hypothyroid condition was 
modeled in Albino rats by giving them 0.02% w/v 
Methimazole (MMI) for three weeks in drinking water; 
one full feeding bottle was consumed daily. Fresh 
solution of MMI was prepared daily. Control group 
received distilled water only. After 4-weeks animals 
from both groups were euthanized with chloroform. 
The blood sample was taken from the rat for 
determination of thyroid hormone concentrations in 
the serum obtained in a usual way from 6 ml of blood 
taken in 10 ml disposable syringe by cardiac puncture. 
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Total serum T3, T4 and TSH concentrations were 
determined by using commercially available enzyme 
Immunoassay test kits (procured from Bio Check, Inc 
323 Vintage Park, dr. Foster City, CA 94404).Each 
animal was killed under anaesthesia, the salivary 
glands were removed. A transverse incision was given 
in the upper part of the neck, skin was carefully 
reflected in the neck and one side of the face to reveal 
these glands. Glands were carefully dissected and 
removed in one piece and were fixed it in Bouin’s 
fluid12. The fixed tissues were processed in automatic 
tissue processor with different strengths of alcohol and 
cleared in xylene. The tissue pieces were embedded in 
paraffin wax and 5m thick sections were obtained 
using a rotary microtome (Leica RM 2125). Glass slides 
with tissue specimen was stain with toluidine blue. 
The identification of mast cells with metachromatic 
granules was done by special stain 1% aqueous 
toluidine blue. The solution of toluidine was prepared 
by dissolving 1gm of toluidine blue powder into 100ml 
of distilled water for 1 minute and PH was adjusted to 
4. The solution was filtered before use. The slides were 
rinsed in water, dehydrated in absolute alcohol, 
cleared in xylene and mounted on DPX. The slides 
were seen using light microscope (Leica DM 1000). 
Mast cell granules stained purple and background 
tissue stained blue. 
Counting the number of MSc  with Graticule: Paraffin 
sections stained with toluidine blue were used to 
determine the  number and distribution of mast cells 
in the salivary glands using light microscope (Leica, 
DM 1000). X40 objective was used for calibrating 
ocular graticule.Ten areas from each slide were 
randomly selected and mast cells were counted at 
X400 magnification . MCS in the control salivary gland 
specimens were counted and compared with mast 
cells in salivary glands after being rendered 
hypothyroid. An eyepiece graticule (0.0625mm2) was 
used in order to avoid overlapping of counting areas. 
Areas selected in each region were surveyed for mast 
cells and the mast cell density was then expressed as 
cell number per unit area. 20 x 20 squares (area = 
1mm2) grid eyepiece graticule engraved on a disc, was 
placed inside the eyepiece of the microscope.Stage 
micrometer, a  3 х 1 inch slide on which 1 mm scale 
divided into 100 equal divisions is engraved, was 
placed under the objective. X 40 objective was selected 
and focused on the stage micrometer scale.Number of 
transverse and vertical segments of ocular graticule 
squares equal to an exact number of divisions of stage 
micrometer scale was determined. 
As each 4 transverse and vertical segments of ocular 
graticule squares were equal to 5 stage divisions, 
therefore: 
100 stage divisions   =  1mm  =   1000 µm 
1 stage division =  1000 / 100 =   10 µm 
4 segments of graticule  =5 stage divisions or 5 х 10  
       =  50 µm 
      1 segment of graticule    =    50 / 4= 12.50 µm 
Area of graticule was calculated by multiplying the 
calibrated factor 12.50 with transverse and vertical 
segments of 20 small squares of the graticule as 
follows: 
 
               (20 x 12.50 = 250 µm or 0.25mm) x (20 x 12.50 = 250 
µm or 0.25mm)   Or 0.25 x 0.25 = 0.0625 mm2 
 
As the counting was done in 10 randomly selected 
fields at X 400 magnification; avoiding overlapping, 
the total area per section was therefore, calculated as 
0.0625 x 10= 0.625mm2. Counting of mast cells was 
performed by superimposing the ocular graticule on 
the salivary gland preparation; the cells were counted 
irrespective of their size but excluding those lying on 
the upper and right edges of the graticule squares to 
avoid counting them more than once.The data was 
entered and analyzed using SPSS 21.0. Mean + S.D 
was given for normally distributed quantitative 




Statistically significant difference was observed 
between the mast cells of parotid gland in group A 
(2.25±1.34/mm2) and B (3.70+1.11/mm2), p<0.017 
(Table.1).However, no significant difference was 
observed in the mean number of mast cells in the 
sublingual and submandibular salivary glands with 
p=0.511 and p=0.187 respectively (Table. 1). Mast cells 
in sections stained with Toluidine blue had various 
size and appearance. They were flat, round or oval 
shaped. Light microscope revealed homogenous   
cytoplasm rather than having a granular appearance. 
It was found that mast cells were predominant near 
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blood vessels within the interlobular connective tissue. 
However, they were also found in the intralobular 
connective tissue around the secretory acini (Fig 1 &2). 
Light microscope revealed homogenous   cytoplasm 
rather than having a granular appearance. It was 
found that mast cells were predominant near blood 
vessels within the interlobular connective tissue. 
However, they were also found in the intralobular 
connective tissue around the secretory acini. 
 
Table. 1: Comparison of the mean number of mast 
cells in salivary glands in groups A & B. 
 
 



















Group A 1.30+0.85 2.33+1.34 2.25+1.34 
Group B 1.53+0.67 3.02+0.84 3.70+1.11 
P-value =0.511 =0.187 <0.017* 
*p value < 0.05 is statistically significant 
 
 
Fig. 1. Parotid gland (Group A): Mast cells (arrows) 
are present within the connective tissue. Toluidine 
blue stain. X 400. 
 
 
Fig. 2.Parotid gland (Group B): Mast cells (arrows) are 
abundantly present within the connective tissue (CT).  
Toluidine blue stain. X 400. 
 
Discussion 
In previous experimental studies on animal models, 
thyroid gland was successfully rendered hypo-
functional upon treating it with MMI.12,24-26 The 
functional state of thyroid gland was established by  
serum levels of T3, T4 and TSH hormones.12 In our 
experimental model, development of hypothyroidism 
was confirmed by changes in the T3, T4 and TSH serum 
levels. Significant decrease in T3, T4 and increase in 
TSH serum levels was indicative that the quantity and 
duration of treatment was sufficient to induce 
hypothyroid status in the experimental group of rats. 
Heterogenicity of mast cells in a variety of organs had 
been reported earlier. 8,27 Additionally, it contributes to 
the process through production of histamine, heparin 
and tryptase. Increase of MCs is associated  with 
different pathological conditions, such as chronic 
inflammatory processes, fibrotic disorders, wound 
healing and neoplastic tissue transformation, but the 
functional significance of the accumulation of mast 
cells in these processes is mostly unknown28. It had 
been established that bone-marrow-derived mast cells 
progenitors circulate in the peripheral blood which 
subsequently migrate into the tissues where they 
undergo final maturation under the influence of local 
micro environmental factors. Oncu et al (2004)  
reported significantly increased number of mast cells 
6-weeks after thyroidectomy in the sublingual gland. 
In the current investigations we found there is a 
statistically significant increase (p<0.017) in the 
number of mast cells in parotid gland when the control 
group was compared with that of the experimental13. 
Whereas, the difference in number of mast cells 
between the control and experimental groups was 
statistically insignificant as for the submandibular and 
sublingual glands respectively. This might be due to 
the fact that parotid gland was most affected in hypo-
functioning thyroid. Regarding sublingual gland, our 
findings were not in accord  with those observed by 
Oncu et al (2004) who reported an increase in the 
number of mast cells; this could possibly be explained 
that the duration of experiment by Oncu  was nearly 
twice as long as in our case.13 
The main reason of most of the organ damage 
associated with hypothyroidism is decreased synthesis 
of number of cellular enzymes associated with thyroid 
hormone deficiency.3MCs through production of 
various cytokines play a leading role in inflammatory  
 processes and in autoimmune diseases pathogenesis28. 
 
Conclusion 
 Due to hypothyroidism, the increase in mast cells is 
observed in different salivary glands in which most 
significant is parotid gland. 
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